Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bradbury Group is a diversified financial services and investment group headquartered in Hong Kong, with a significant focus on the life sciences and healthcare sectors. Through its subsidiary, Bradbury Asset Management, the firm operates specialized investment vehicles such as the Bradbury Life Sciences Fund, which targets high-growth opportunities in biotechnology, medical devices, and healthcare technology. The group acts as a strategic investor and holding company, providing capital and operational support to emerging biotech firms primarily in the Asia-Pacific region and North America. While not a drug developer itself, Bradbury Group plays a critical role in the life sciences ecosystem by financing clinical-stage companies and facilitating cross-border partnerships in the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bradbury Group.